SL Therapeutics, Inc.

XKON:A258540 Stock Report

Market Cap: ₩4.7b

SL Therapeutics, Inc. Company Information

SL Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: SL Therapeutics, Inc.
  • Ticker: A258540
  • Exchange: XKON
  • Founded: 2011
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₩4.745b
  • Shares Outstanding: 5.21m
  • Website: https://www.stemlab.co.kr

Location

  • SL Therapeutics, Inc.
  • 711, Techno Complex of Korea University
  • 145, Anam-ro
  • Seoul
  • 02841
  • South Korea


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
A258540XKON (Korea New Exchange)YesShare CapitalKRKRWMar 2017

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/19 22:34
End of Day Share Price 2024/11/19 00:00
EarningsN/A
Annual EarningsN/A


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.